Bajraktari-Sylejmani, G., Piribauer, M., Größl, S., Bernhard, P., Dyckhoff, G., Warta, R., . . . Weiß, J. (2025). Kynurenine enhances aryl hydrocarbon receptor signaling and expression levels of multidrug resistance genes in head and neck squamous cell carcinoma cell lines but does not change the potency of antineoplastic drugs. Toxicology and applied pharmacology, 502, . https://doi.org/10.1016/j.taap.2025.117443
Chicago Style (17th ed.) CitationBajraktari-Sylejmani, Gzona, Marlene Piribauer, Sven Größl, Patrick Bernhard, Gerhard Dyckhoff, Rolf Warta, Christel Herold-Mende, Dirk Theile, and Johanna Weiß. "Kynurenine Enhances Aryl Hydrocarbon Receptor Signaling and Expression Levels of Multidrug Resistance Genes in Head and Neck Squamous Cell Carcinoma Cell Lines but Does Not Change the Potency of Antineoplastic Drugs." Toxicology and Applied Pharmacology 502 (2025). https://doi.org/10.1016/j.taap.2025.117443.
MLA (9th ed.) CitationBajraktari-Sylejmani, Gzona, et al. "Kynurenine Enhances Aryl Hydrocarbon Receptor Signaling and Expression Levels of Multidrug Resistance Genes in Head and Neck Squamous Cell Carcinoma Cell Lines but Does Not Change the Potency of Antineoplastic Drugs." Toxicology and Applied Pharmacology, vol. 502, 2025, https://doi.org/10.1016/j.taap.2025.117443.